Dr. Slavin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2430 Cross St
La Crescenta, CA 91214Phone+1 626-256-8662
Summary
- Dr. Thomas Slavin is a medical geneticist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of South Florida College of Medicine and has been in practice 12 years. He specializes in clinical cancer genetics.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pediatrics/Medical Genetics and Genomics, 2005 - 2010
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2005 - 2008
- University of South Florida College of MedicineClass of 2005
- University of South FloridaB.S., Biology, Cum Laude, 1997 - 2001
Certifications & Licensure
- CA State Medical License 2014 - 2026
- HI State Medical License 2010 - 2016
- OH State Medical License 2005 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
- American Board of Clinical ChemistryBoard certification in Molecular Diagnostics
Awards, Honors, & Recognition
- Research Career Development Award Recipient STOP CANCER, 2015
- Fellow American College of Medical Genetics and Genomics, 2012
- Pediatric Residency International Health Track Distinction (Roatan, Honduras) 2008
- Join now to see all
Publications & Presentations
PubMed
- 35 citationsThe effects of genomic germline variant reclassification on clinical cancer care.Thomas P. Slavin, Sophia Manjarrez, Colin C. Pritchard, Stacy W. Gray, Jeffrey N. Weitzel
Oncotarget. 2019-01-11 - 90 citationsEvaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N. Maxwell, Steven N. Hart, Joseph Vijai, Kasmintan A. Schrader, Thomas P. Slavin
American Journal of Human Genetics. 2016-05-05 - 15 citationsGenetic associations of relaxin: preterm birth and premature rupture of fetal membranes.Frederico G. Rocha, Thomas P. Slavin, Dongmei Li, Maarit Tiirikainen, Gillian D. Bryant-Greenwood
American Journal of Obstetrics and Gynecology. 2013-09-01
Journal Articles
- Specifications of the ACMG/AMP Variant Curation Guidelines for the Analysis of Germline CDH1 Sequence VariantsSharon E Plon, Chimene Kesserwan, Thomas P Slavin, Liying Zhang, Human Mutation
- Clinical application of multigene panels: challenges of next-generation counseling and cancer risk managementSlavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN, Front. Oncol., 1/29/2015
- Congenital diaphragmatic hernia in a fetus with a de novo terminal deletion of chromosome 15q261Ruth C, Starcevic J, Bartholomew ML, Qin N, Slavin TP, Hereditary Genetics, 1/1/2012
Books/Book Chapters
Abstracts/Posters
- How big of a role does TP53 play in BRCA1/2 negative familial breast cancer? Data from the SIMPLEXO consortium.Slavin TP, Maxwell KN, Hart S, Vijai J, Schrader K, Guidugli L, Thomas T, Moore R, Hu C, Wubbenhorst B, Domchek SM, Robson ME, Radice P, Peterlongo P, Ford J, Garber J..., American Society of Human Genetics Annual Meeting, Baltimore, MD, 1/1/2015
- The contribution of high and moderate penetrance breast cancer susceptibility genes to familial breast cancer risk in BRCAx families.Maxwell KN, Hart S, Vijai J, Schrader K, Slavin TP, Thomas T, Moore R, Hu C, Wubbenhorst B, Domchek SM, Robson ME, Radice P, Peterlongo P, Ford J, Garber J, Szabo C, N..., American Society of Human Genetics Annual Meeting, 1/1/2015
- Hereditary susceptibility to pancreatic cancer.Raja S, Sand S, Weitzel JN, Yang K, Slavin TP, Eugene and Ruth Roberts Summer Academy Poster Presentation, City of Hope, Duarte, CA, 1/1/2015
- Join now to see all
Lectures
- Effect of germline ATM mutations on clonal hematopoiesis.2019 ASCO Annual Meeting - 6/1/2019
- Understanding the NGS Test report: a primer on genomics nomenclature.1/27/2015
- Updates in Li Fraumeni syndrome screening.City of Hope - 1/26/2015
- Join now to see all
Other
- "Genodermatoses in cancer"Slavin TP, Intensive Course in Cancer Genetics (Video)
City of Hope - 1/10/2014 - Visual Diagnosis: Newborn with Unilateral Lower Extremity Vascular Malformation and Limb Asymmetry.Wong Ramsey K, Slavin TP, Tjoeng T, Jain S, NeoReviews Vol. 15 No. 2
http://neoreviews.aappublications.org/content/15/2/e82.short
1/1/2014 - "Genetic Testing"Slavin TP, The Body Show with Kathy Kozak, Hawai'i Public Radio
1/10/2013
Press Mentions
- Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard-of-Care Risk ModelDecember 9th, 2022
- What Causes Breast Cancer, Exactly? Doctors Explain What We Know—and How Testing Can HelpMay 5th, 2022
- Genomic Instability Varies Between Breast Cancer SubtypesDecember 10th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: